BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 21456046)

  • 1. p14Arf acts as an antagonist of HMGA2 in senescence of mesenchymal stem cells-implications for benign tumorigenesis.
    Markowski DN; Winter N; Meyer F; von Ahsen I; Wenk H; Nolte I; Bullerdiek J
    Genes Chromosomes Cancer; 2011 Jul; 50(7):489-98. PubMed ID: 21456046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HMGA2 and p14Arf: major roles in cellular senescence of fibroids and therapeutic implications.
    Markowski DN; Helmke BM; Belge G; Nimzyk R; Bartnitzke S; Deichert U; Bullerdiek J
    Anticancer Res; 2011 Mar; 31(3):753-61. PubMed ID: 21498692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Permanent activation of HMGA2 in lipomas mimics its temporal physiological activation linked to the gain of adipose tissue.
    Thies HW; Nolte I; Wenk H; Mertens F; Bullerdiek J; Markowski DN
    Obesity (Silver Spring); 2014 Jan; 22(1):141-50. PubMed ID: 24106133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMGA2 and the p19Arf-TP53-CDKN1A axis: a delicate balance in the growth of uterine leiomyomas.
    Markowski DN; von Ahsen I; Nezhad MH; Wosniok W; Helmke BM; Bullerdiek J
    Genes Chromosomes Cancer; 2010 Aug; 49(8):661-8. PubMed ID: 20544840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamics of senescent cell formation and retention revealed by p14ARF induction in the epidermis.
    Tokarsky-Amiel R; Azazmeh N; Helman A; Stein Y; Hassan A; Maly A; Ben-Porath I
    Cancer Res; 2013 May; 73(9):2829-39. PubMed ID: 23423975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p53-induced apoptosis occurs in the absence of p14(ARF) in malignant pleural mesothelioma.
    Hopkins-Donaldson S; Belyanskaya LL; Simões-Wüst AP; Sigrist B; Kurtz S; Zangemeister-Wittke U; Stahel R
    Neoplasia; 2006 Jul; 8(7):551-9. PubMed ID: 16867217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent alteration of p16(INK4a)/p14(ARF) and p53 pathways in the round cell component of myxoid/round cell liposarcoma: p53 gene alterations and reduced p14(ARF) expression both correlate with poor prognosis.
    Oda Y; Yamamoto H; Takahira T; Kobayashi C; Kawaguchi K; Tateishi N; Nozuka Y; Tamiya S; Tanaka K; Matsuda S; Yokoyama R; Iwamoto Y; Tsuneyoshi M
    J Pathol; 2005 Dec; 207(4):410-21. PubMed ID: 16177957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BMP4 increases expression of HMGA2 in mesenchymal stem cells.
    Markowski DN; Helmke BM; Meyer F; von Ahsen I; Nimzyk R; Nolte I; Bullerdiek J
    Cytokine; 2011 Dec; 56(3):811-6. PubMed ID: 22019704
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p14ARF expression increases dihydrofolate reductase degradation and paradoxically results in resistance to folate antagonists in cells with nonfunctional p53.
    Magro PG; Russo AJ; Li WW; Banerjee D; Bertino JR
    Cancer Res; 2004 Jun; 64(12):4338-45. PubMed ID: 15205349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ink4a/Arf regulation by let-7b and Hmga2: a genetic pathway governing stem cell aging.
    Tzatsos A; Bardeesy N
    Cell Stem Cell; 2008 Nov; 3(5):469-70. PubMed ID: 18983959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic alterations of INK4alpha/ARF locus and p53 in human hepatocellular carcinoma.
    Peng CY; Chen TC; Hung SP; Chen MF; Yeh CT; Tsai SL; Chu CM; Liaw YF
    Anticancer Res; 2002; 22(2B):1265-71. PubMed ID: 12168936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical [corrected] detection of the alternate INK4a-encoded tumor suppressor protein p14(ARF) in archival human cancers and cell lines using commercial antibodies: correlation with p16(INK4a) expression.
    Geradts J; Wilentz RE; Roberts H
    Mod Pathol; 2001 Nov; 14(11):1162-8. PubMed ID: 11706079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low p14ARF expression in neuroblastoma cells is associated with repressed histone mark status, and enforced expression induces growth arrest and apoptosis.
    Dreidax D; Gogolin S; Schroeder C; Muth D; Brueckner LM; Hess EM; Zapatka M; Theißen J; Fischer M; Ehemann V; Schwab M; Savelyeva L; Westermann F
    Hum Mol Genet; 2013 May; 22(9):1735-45. PubMed ID: 23343716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of the p14(ARF) gene and p53 status in human hepatocellular carcinomas.
    Ito T; Nishida N; Fukuda Y; Nishimura T; Komeda T; Nakao K
    J Gastroenterol; 2004; 39(4):355-61. PubMed ID: 15168247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recovery of function in osteoarthritic chondrocytes induced by p16INK4a-specific siRNA in vitro.
    Zhou HW; Lou SQ; Zhang K
    Rheumatology (Oxford); 2004 May; 43(5):555-68. PubMed ID: 15026580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression of senescence markers p14(ARF) and p16(INK4a) in breast cancer is associated with an increased risk of disease recurrence and poor survival outcome.
    Pare R; Shin JS; Lee CS
    Histopathology; 2016 Sep; 69(3):479-91. PubMed ID: 26843058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human p14(ARF)-mediated cell cycle arrest strictly depends on intact p53 signaling pathways.
    Weber HO; Samuel T; Rauch P; Funk JO
    Oncogene; 2002 May; 21(20):3207-12. PubMed ID: 12082636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rb protein is essential to the senescence-associated heterochromatic foci formation induced by HMGA2 in primary WI38 cells.
    Shi X; Tian B; Liu L; Gao Y; Ma C; Mwichie N; Ma W; Han L; Huang B; Lu J; Zhang Y
    J Genet Genomics; 2013 Aug; 40(8):391-8. PubMed ID: 23969248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenovirus-mediated overexpression of p14(ARF) induces p53 and Bax-independent apoptosis.
    Hemmati PG; Gillissen B; von Haefen C; Wendt J; Stärck L; Güner D; Dörken B; Daniel PT
    Oncogene; 2002 May; 21(20):3149-61. PubMed ID: 12082630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between p14(ARF)/p16(INK4A) expression and HPV infection in uterine cervical cancer.
    Kanao H; Enomoto T; Ueda Y; Fujita M; Nakashima R; Ueno Y; Miyatake T; Yoshizaki T; Buzard GS; Kimura T; Yoshino K; Murata Y
    Cancer Lett; 2004 Sep; 213(1):31-7. PubMed ID: 15312681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.